Silk polymer-based adenosine release: therapeutic potential for epilepsy.
暂无分享,去创建一个
David L Kaplan | Eleanor M. Pritchard | D. Kaplan | Eleanor M Pritchard | Detlev Boison | J. Lan | Tianfu Li | Tianfu Li | Jing-Quan Lan | Andrew Wilz | D. Boison | Andrew Wilz | D. Kaplan
[1] Peng Xu,et al. Biomaterial coatings by stepwise deposition of silk fibroin. , 2005, Langmuir : the ACS journal of surfaces and colloids.
[2] M B McCarthy,et al. Functionalized silk-based biomaterials for bone formation. , 2001, Journal of biomedical materials research.
[3] Vladimir Volloch,et al. Bone morphogenetic protein-2 decorated silk fibroin films induce osteogenic differentiation of human bone marrow stromal cells. , 2004, Journal of biomedical materials research. Part A.
[4] E. Kossoff,et al. Decreased relative efficacy of the ketogenic diet for children with surgically approachable epilepsy , 2007, Seizure.
[5] S. Rosenfeld,et al. Reactions of 1-N6-ethenoadenosine nucleotides with myosin subfragment 1 and acto-subfragment 1 of skeletal and smooth muscle. , 1984, The Journal of biological chemistry.
[6] R. Raedt,et al. Cell therapy in models for temporal lobe epilepsy , 2007, Seizure.
[7] N. de Tribolet,et al. Preoperative silk suture embolization of cerebral and dural arteriovenous malformations. , 2001, Neurosurgical focus.
[8] K. Thompson. Genetically engineered cells with regulatable GABA production can affect afterdischarges and behavioral seizures after transplantation into the dentate gyrus , 2005, Neuroscience.
[9] David L. Kaplan,et al. Mechanism of silk processing in insects and spiders , 2003, Nature.
[10] Robert E. Schmidt,et al. Cooling produces minimal neuropathology in neocortex and hippocampus , 2006, Neurobiology of Disease.
[11] David L Kaplan,et al. Silk-based biomaterials. , 2003, Biomaterials.
[12] N. Déglon,et al. Grafts of adenosine-releasing cells suppress seizures in kindling epilepsy , 2001, Proceedings of the National Academy of Sciences of the United States of America.
[13] T. McCown. Adeno-associated virus-mediated expression and constitutive secretion of galanin suppresses limbic seizure activity in vivo. , 2006, Molecular therapy : the journal of the American Society of Gene Therapy.
[14] P. Aebischer,et al. Seizure Suppression in Kindled Rats by Intraventricular Grafting of an Adenosine Releasing Synthetic Polymer , 1999, Experimental Neurology.
[15] J. Fritschy,et al. Seizure Suppression by Adenosine A1 Receptor Activation in a Mouse Model of Pharmacoresistant Epilepsy , 2003, Epilepsia.
[16] I. Trayer,et al. Preparation of adenosine nucleotide derivatives suitable for affinity chromatography. , 1974, The Biochemical journal.
[17] D. Boison. Adenosine-Based Cell Therapy Approaches for Pharmacoresistant Epilepsies , 2007, Neurodegenerative Diseases.
[18] D. Boison. The adenosine kinase hypothesis of epileptogenesis , 2008, Progress in Neurobiology.
[19] Jiang Lan,et al. Lentiviral RNAi-induced downregulation of adenosine kinase in human mesenchymal stem cell grafts: A novel perspective for seizure control , 2007, Experimental Neurology.
[20] A. Shetty,et al. Concise Review: Prospects of Stem Cell Therapy for Temporal Lobe Epilepsy , 2007, Stem cells.
[21] G. Vunjak‐Novakovic,et al. Silk fibroin as an organic polymer for controlled drug delivery. , 2006, Journal of controlled release : official journal of the Controlled Release Society.
[22] Shigeyoshi Itohara,et al. Adenosine kinase is a target for the prediction and prevention of epileptogenesis in mice. , 2008, The Journal of clinical investigation.
[23] M. Nitsche,et al. Anticonvulsant Effects of Transcranial Direct‐current Stimulation (tDCS) in the Rat Cortical Ramp Model of Focal Epilepsy , 2006, Epilepsia.
[24] David L Kaplan,et al. Electrospun silk-BMP-2 scaffolds for bone tissue engineering. , 2006, Biomaterials.
[25] U. Heinemann,et al. Cell and gene therapies in epilepsy – promising avenues or blind alleys? , 2008, Trends in Neurosciences.
[26] R. Simon,et al. Suppression of kindling epileptogenesis by adenosine releasing stem cell-derived brain implants. , 2007, Brain : a journal of neurology.
[27] David L Kaplan,et al. In vitro degradation of silk fibroin. , 2005, Biomaterials.
[28] N. Neff,et al. Adenosine Measurement by a Rapid HPLC‐Fluorometric Method: Induced Changes of Adenosine Content in Regions of Rat Brain , 1982, Journal of neurochemistry.
[29] A. Pitkänen,et al. Gene therapy in epilepsy: The focus on NPY , 2007, Peptides.
[30] Asla Pitkänen,et al. Epileptogenesis in Experimental Models , 2007, Epilepsia.
[31] Hannah R Cock,et al. Focal treatment for refractory epilepsy: hope for the future? , 2004, Brain Research Reviews.
[32] R. D'Hooge,et al. Pathophysiology of epilepsy. , 2000, Acta neurologica Belgica.
[33] O. Brüstle,et al. Suppression of Kindled Seizures by Paracrine Adenosine Release from Stem Cell–Derived Brain Implants , 2005, Epilepsia.
[34] F. Vajda. Pharmacotherapy of epilepsy: New armamentarium, new issues , 2007, Journal of Clinical Neuroscience.
[35] David L Kaplan,et al. Silk coatings on PLGA and alginate microspheres for protein delivery. , 2007, Biomaterials.
[36] J. Fritschy,et al. Overexpression of Adenosine Kinase in Epileptic Hippocampus Contributes to Epileptogenesis , 2022 .
[37] S. Masino,et al. Are purines mediators of the anticonvulsant/neuroprotective effects of ketogenic diets? , 2008, Trends in Neurosciences.
[38] J. Naegele,et al. Region‐specific differentiation of embryonic stem cell‐derived neural progenitor transplants into the adult mouse hippocampus following seizures , 2008, Journal of neuroscience research.
[39] W. Pralong,et al. Seizure suppression and lack of adenosine A1 receptor desensitization after focal long-term delivery of adenosine by encapsulated myoblasts , 2005, Experimental Neurology.
[40] John S Duncan,et al. Adult epilepsy , 2006, The Lancet.
[41] Ung-Jin Kim,et al. Three-dimensional aqueous-derived biomaterial scaffolds from silk fibroin. , 2005, Biomaterials.
[42] H. Winn,et al. Embolization of cerebral arteriovenous malformations with silk: histopathologic changes and hemorrhagic complications. , 1997, AJNR. American journal of neuroradiology.
[43] N. Déglon,et al. Seizure Suppression by Adenosine‐releasing Cells Is Independent of Seizure Frequency , 2002, Epilepsia.
[44] A. Brooks-Kayal,et al. Enhancing GABAA Receptor α1 Subunit Levels in Hippocampal Dentate Gyrus Inhibits Epilepsy Development in an Animal Model of Temporal Lobe Epilepsy , 2006, The Journal of Neuroscience.
[45] Kristl Vonck,et al. High Frequency Deep Brain Stimulation in the Hippocampus Modifies Seizure Characteristics in Kindled Rats , 2007, Epilepsia.
[46] D. Boison. Cell and gene therapies for refractory epilepsy. , 2007, Current neuropharmacology.
[47] R. Haberman,et al. Adeno-associated virus-mediated expression and constitutive secretion of NPY or NPY13-36 suppresses seizure activity in vivo , 2007, Gene Therapy.
[48] Takahiro Takano,et al. Adenosine is crucial for deep brain stimulation–mediated attenuation of tremor , 2008, Nature Medicine.
[49] A. Vezzani. The promise of gene therapy for the treatment of epilepsy , 2007, Expert review of neurotherapeutics.